Kenneth Galbraith, Director at MACROGENICS INC (MGNX), bought 62,190 shares at $16.00 ($750K) on 2013-10-16, disclosed to the SEC on 2013-10-18.
Open-market purchase of $750k MGNX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,315 | $0 | 0.0% |
| 2 | $16.00 | 46,875 | $750K | 100.0% |
| Total | $12.06 avg | 62,190 | $750K | 100% |
| Filing → |
| ZYME | SELL | 2025-12-22 | $2.6M | — | Filing → |
| ZYME | SELL | 2025-01-06 | $1.7M | — | Filing → |
| ZYME | SELL | 2024-01-08 | $516K | — | Filing → |